SEATTLE & TOKYO--(BUSINESS WIRE)--Rosetta Biosoftware announced today that Eisai Co., Ltd. licensed the Elucidator® system for differential protein expression analysis and biomarker discovery. Eisai Co., one of the largest pharmaceutical companies in Japan, will be using the Elucidator system in the Laboratory of Seeds Finding Technology to support LC-MS quantification methods for identifying potential neurology biomarkers.
